Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:57 PM
Ignite Modification Date:
2025-12-24 @ 4:57 PM
NCT ID:
NCT02330250
Eligibility Criteria:
Inclusion criteria:
* SLE diagnosis according to the 2012 SLICC (Systemic Lupus International Collaborating Clinics Group) SLE classification criteria.
* Treatment with corticosteroids and antimalarials.
* History of biopsy-proven lupus nephritis classes III, IV, or V (2003 International Society of Nephrology / Renal Pathology Society) or nephritic/nephrotic lupus flare not undergone to kidney biopsy.
Exclusion Criteria:
* Current renal replacement therapy.
* Renal transplantation.
* Ongoing pulse therapy with cyclophosphamide and/or methylprednisolone.
* Aid by caregiver.
* Any psychiatric illness.
* Inability to understand the questions of the questionnaire.
* Patients'unwillingness to sign the informed consent.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT02330250
Study Brief:
Protocol Section:
NCT02330250